biostudies-literatureUnknown17(24)Timiryasova A<b>Background/Objectives</b>: Whilst cancer is a leading cause of death in people with HIV, less is known about clinical outcomes after cancer. <b>Methods</b>: Participants from the RESPOND and D:A:D cohorts with the five most common cancers (Kaposi's sarcoma (KS); non-Hodgkin lymphoma (NHL); and lung, anal and prostate cancers) were followed from first cancer diagnosis after 2006/2012 [D:A:D/RESPOND] until death, final follow-up or administrative censoring (2016/2021). Incidence rates (IR) were calculated for post-cancer mortality; for non-fatal events (cardiovascular disease, diabetes, another primary cancer, AIDS events) individually and as a non-fatal composite clinical outcome (CCO). Predictors or mortality and CCO were assessed using Poisson regression with generalized estimating equCancers4000https://www.ebi.ac.uk/biostudies/studies/S-EPMC12731807biostudies-literatureMortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.PMC12731807Egle ACingolani AGrabmeier-Pfistershammer KMarongiu AOn Behalf Of The D A D And Respond Study GroupsAmstutz AWit FBonnet FBottanelli MGarges HPeters LLehmann CCastagna ADomingo PYoung LATimiryasova APetoumenos KLundgren JGreenberg LTarr PECarlander CMartin CSabin CAHosein SMussini CRyom LfalseMortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration.<b>Background/Objectives</b>: Whilst cancer is a leading cause of death in people with HIV, less is known about clinical outcomes after cancer. <b>Methods</b>: Participants from the RESPOND and D:A:D cohorts with the five most common cancers (Kaposi's sarcoma (KS); non-Hodgkin lymphoma (NHL); and lung, anal and prostate cancers) were followed from first cancer diagnosis after 2006/2012 [D:A:D/RESPOND] until death, final follow-up or administrative censoring (2016/2021). Incidence rates (IR) were calculated for post-cancer mortality; for non-fatal events (cardiovascular disease, diabetes, another primary cancer, AIDS events) individually and as a non-fatal composite clinical outcome (CCO). Predictors or mortality and CCO were assessed using Poisson regression with generalized estimating equ2025-01-01T00:00:00Z2025 Dec2026-05-28T03:17:50.268Z2026-05-28T03:07:26.209ZS-EPMC127318074146324910.3390/cancers17244000